Sunil Singhania-owned Abqus on Friday bought stake in TTK Healthcare through an open market transaction.
Sunil Singhania-led asset management firm Abacus Asset Manager LLP bought 131,788 equity shares of TTK Healthcare at average price. 911.08 each.
Whereas, Abakkus Diversified Alpha Fund has generated . bought 115,385 shares at an average price of 910 per share on the BSE, as per the wholesale deals data available with the exchange. The net worth of this stake is 22.5 crores.
Mcap India Fund, managed by Gurgaon-based private equity firm Mcap Fund Advisors, sold 245,873 lakh equity shares in TTK Healthcare at an average price. 910 per share.
TTK Healthcare rose nearly 13 percent 1,022.70 on BSE. The stock has a 52-week high 1,105.90 each and is a 52-week low 667.50 respectively. Its market capitalization is 1,445.11 crores.
TTK Healthcare Ltd’s standalone net profit almost flat in the quarter ended December 12 crores.
Stake,
Net profit reported by the healthcare provider 12.17 crore during the year-ago period, including gain from discontinued operations.
increased revenue from operations 183 crores to 159 crore while input cost increased by 23% 48 crore, it said in a regulatory filing.
Indian stocks suffered losses for the third straight week amid volatility and widespread selling after the government hiked the Securities Transaction Tax (STT) on futures and options contracts along with other amendments in the Finance Bill 2023.
All sectoral indices ended in the red with Media, Metal, Realty and PSU Bank showing maximum losses. IT remained strong throughout the session but ended with minor losses.
The Nifty 50 index declined 0.77 per cent to close 131.90 points at 16,945.05, breaching the psychological level of 17,000. The S&P BSE Sensex closed 398.18 points or 0.69 per cent lower at 57,527.10. Both the benchmarks registered weekly losses of around 1 per cent.
